Regarding expanded access, I think a good move would have been to seek eIND for children with MIS-C brought upon by Covid. 1) doesn't interfere with current trials or future trials (can't imagine any ethical way to allow placebo trials with child mortality) 2) saving precious children's lives 3) the good will & coverage from saving children's lives would go viral and spread like wildfire!

Anyone with close contact to CYDY please make the suggestion. I think this should be their next move.